1. 10LBA Final results of the prospective DDFMISO-trial validating hypoxiaspecific PET imaging during radiochemotherapy for local control of locally advanced head-and-neck cancer. Issue 3 (September 2015) Authors: Seidlitz, A.; Perrin, R.; Bandurska-Luque, A.; Zöphel, K.; Löck, S.; Abolmaali, N.; Haase, R.; Zschaeck, S.; Krause, M.; Steinbach, J.; Kotzerke, J.; Zips, D.; Baumann, M. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0262: Comparison of machine-learning methods for predictive radiomic models in locally advanced HNSCC. (April 2016) Authors: Leger, S.; Bandurska-Luque, A.; Pilz, K.; Zöphel, K.; Baumann, M.; Troost, E.G.C.; Löck, S.; Richter, C. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0269: Comparison of tumour hypoxia measured by FMISO-PET and gene signatures for patients with HNSCC. (April 2018) Authors: Löck, S.; Linge, A.; Seidlitz, A.; Bandurska-Luque, A.; Großer, M.; Baretton, G.; Zöphel, K.; Zips, D.; Troost, E.; Krause, M.; Baumann, M. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Parallel assessment of hypoxia in tumor and LN metastases increases prognostic value of hypoxia-specific PET imaging in locally advanced head-and-neck cancer – secondary analysis of the DDFMISO trial. (February 2017) Authors: Bandurska-Luque, A.; Löck, S.; Haase, R.; Zöphel, K.; Abolmaali, N.; Seidlitz, A.; Perrin, R.; Richter, C.; Troost, E.G.; Steinbach, J.; Zips, D.; Krause, M.; Baumann, M. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0898: Identification of individual NTCP benefit of dose-escalated IMPT in advanced HNC patients. (April 2015) Authors: Jakobi, A.; Bandurska-Luque, A.; Stützer, K.; Haase, R.; Löck, S.; Wack, L.; Mönnich, D.; Thorwarth, D.; Kovacevic, M.; Perez, D.; Lühr, A.; Zips, D.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0951 Effects of COVID-19 during radio(chemo)therapy in head and neck cancer patients. (August 2021) Authors: Bandurska-Luque, A.; Winiecki, T.; Żmijewska-Tomczak, M.; Poźniak-Balicka, R.; Adamska, A.; Bajon, T.; Borowczak, D.; Milecki, P.; Kaźmierska, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1115 First year survival data on COVID-19 outbreak during radiotherapy course in head and neck cancer. (May 2022) Authors: Bandurska-Luque, A.; Poźniak-Balicka, R.; Winiecki, T.; Bajon, T.; Adamska, A.; Żmijewska-Tomczak, M.; Milecki, P.; Kaźmierska, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗